Journal
GENE THERAPY
Volume 16, Issue 10, Pages 1189-1201Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2009.81
Keywords
allosteric; aptamer; directed evolution; riboswitch; ribozyme; RNA switch
Categories
Funding
- Howard Hughes Medical Institute
- NSF
- NIH
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068819] Funding Source: NIH RePORTER
Ask authors/readers for more resources
In the last two decades, remarkable advances have been made in the development of technologies used to engineer new aptamers and ribozymes. This has encouraged interest among researchers who seek to create new types of gene-control systems that can be made to respond specifically to small-molecule signals. Validation of the fact that RNA molecules can exhibit the characteristics needed to serve as precision genetic switches has come from the discovery of numerous classes of natural ligand-sensing RNAs called riboswitches. Although a great deal of progress has been made toward engineering useful designer riboswitches, considerable advances are needed before the performance characteristics of these RNAs match those of protein systems that have been co-opted to regulate gene expression. In this review, we will evaluate the potential for engineered RNAs to regulate gene expression and lay out possible paths to designer riboswitches based on currently available technologies. Furthermore, we will discuss some technical advances that would empower RNA engineers who seek to make routine the production of designer riboswitches that can function in eukaryotes. Gene Therapy (2009) 16, 1189-1201; doi: 10.1038/gt.2009.81; published online 9 July 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available